Direkt zum Inhalt
Merck

1650006

USP

Tetracain -hydrochlorid

United States Pharmacopeia (USP) Reference Standard

Synonym(e):

4-(Butylamino)-benzoesäure-2-(dimethylamino)-ethylester, Amethocain -hydrochlorid

Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise


About This Item

Empirische Formel (Hill-System):
C15H24N2O2 · HCl
CAS-Nummer:
Molekulargewicht:
300.82
MDL-Nummer:
UNSPSC-Code:
41116107
PubChem Substanz-ID:
NACRES:
NA.24

Qualität

pharmaceutical primary standard

API-Familie

tetracaine

Hersteller/Markenname

USP

Anwendung(en)

pharmaceutical (small molecule)

Format

neat

SMILES String

Cl.CCCCNc1ccc(cc1)C(=O)OCCN(C)C

InChI

1S/C15H24N2O2.ClH/c1-4-5-10-16-14-8-6-13(7-9-14)15(18)19-12-11-17(2)3;/h6-9,16H,4-5,10-12H2,1-3H3;1H

InChIKey

PPWHTZKZQNXVAE-UHFFFAOYSA-N

Suchen Sie nach ähnlichen Produkten? Aufrufen Leitfaden zum Produktvergleich

Allgemeine Beschreibung

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Anwendung

Tetracaine hydrochloride USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monographs such as:
  • Benzocaine, Butamben, and Tetracaine Hydrochloride Gel
  • Benzocaine, Butamben, and Tetracaine Hydrochloride Ointment
  • Benzocaine, Butamben, and Tetracaine Hydrochloride Topical Aerosol®
  • Benzocaine, Butamben, and Tetracaine Hydrochloride Topical Solution
  • Lidocaine, Racepinephrine, and Tetracaine Hydrochlorides Compounded Topical Gel
  • Neomycin Sulfate, Isoflupredone Acetate, and Tetracaine Hydrochloride Ointment
  • Neomycin Sulfate, Isoflupredone Acetate, and Tetracaine Hydrochloride Topical Powder
Topisches Augenanästhetikum; angewendet bei Rückenmarkanästhesie

Biochem./physiol. Wirkung

Hemmt spannungsempfindliche Freisetzung von Ca2+ aus sarkoplasmatischem Retikulum.

Hinweis zur Analyse

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Sonstige Hinweise

Sales restrictions may apply.

Rechtliche Hinweise

Aerosol is a registered trademark of Cytec Technology Corp.

Ähnliches Produkt

Produkt-Nr.
Beschreibung
Preisangaben

Piktogramme

Skull and crossbones

Signalwort

Danger

Gefahreneinstufungen

Acute Tox. 3 Oral - Eye Irrit. 2 - STOT SE 3

Zielorgane

Central nervous system

Lagerklassenschlüssel

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

WGK

WGK 3

Flammpunkt (°F)

Not applicable

Flammpunkt (°C)

Not applicable


Analysenzertifikate (COA)

Suchen Sie nach Analysenzertifikate (COA), indem Sie die Lot-/Chargennummer des Produkts eingeben. Lot- und Chargennummern sind auf dem Produktetikett hinter den Wörtern ‘Lot’ oder ‘Batch’ (Lot oder Charge) zu finden.

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

Elisa Cinotti et al.
American journal of ophthalmology, 159(2), 324-333 (2014-12-03)
To evaluate whether the handheld in vivo reflectance confocal microscopy that has been recently developed for the study of skin tumors is suitable for the diagnosis of conjunctival tumors. Prospective study, observational case series. We prospectively evaluated the reflectance confocal
Genea Edwards et al.
Biochimie, 105, 99-109 (2014-07-12)
To identify the sphingolipid and ceramide species and their quantitative differences between normotensive and hypertensive intraocular pressure states in DBA/2J mouse aqueous humor (AH). Normotensive and hypertensive AH was sampled from mice by paracentesis. Lipid extraction was performed using modifications
Sara Brittingham et al.
Investigative ophthalmology & visual science, 55(12), 8371-8376 (2014-12-04)
To compare the occurrence rate and depth of the demarcation line and topographical outcome after corneal cross-linking (CXL) for keratoconus using two different treatment protocols. A retrospective analysis of 131 eyes with progressive keratoconus treated with CXL using riboflavin and
Akihiro Tanaka et al.
Antimicrobial agents and chemotherapy, 58(8), 4380-4383 (2014-05-21)
We have reported significantly higher convulsion prevalence in patients treated with cefepime than in those treated with meropenem. Additionally, cefepime-associated convulsions were found only in patients with brain disorders, not renal failure. Here, we compared the convulsive liability of cefepime
Angel Nava-Castañeda et al.
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 31(2), 106-113 (2014-11-05)
The aim of the study was to evaluate the effect of 3 subconjunctival bevacizumab injections in patients with an early corneal pterygium recurrence. This study was a nonrandomized single center trial. Patients with an early corneal pterygium recurrence were selected.

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung.